Healthcare -
Biotechnology - NASDAQ - US
$ 11.465
-3.17 %
$ 37.3 M
Market Cap
-0.68
P/E
SRZN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SRZN - Surrozen, Inc.
276 K
LAST VALUE
-95.29%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR